<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordsOutput xmlns:ns2="local"><serviceExecutionTime>339</serviceExecutionTime><Drug id="81916"><DrugName>human immunoglobulin (iv, pH4), Sino-Korean Anhui Green Cross Biological Products</DrugName><DrugSynonyms><Name><Value>human immunoglobulin (iv, pH4), Sino-Korean Anhui Green Cross Biological Products</Value></Name></DrugSynonyms><CompanyOriginator id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</CompanyOriginator><CompaniesPrimary><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company></CompaniesPrimary><CrossReferences><SourceEntity id="14959" type="Company"><TargetEntity id="5035555084" type="organizationId">Green Cross China Biological Products Co Ltd</TargetEntity></SourceEntity><SourceEntity id="1133" type="ciIndication"><TargetEntity id="10043561" type="MEDDRA"></TargetEntity><TargetEntity id="D011697" type="MeSH"></TargetEntity><TargetEntity id="-241656606" type="omicsDisease"></TargetEntity><TargetEntity id="1491" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="3839" type="ciIndication"><TargetEntity id="10020983" type="MEDDRA"></TargetEntity></SourceEntity><SourceEntity id="746" type="ciIndication"><TargetEntity id="10021789" type="MEDDRA"></TargetEntity><TargetEntity id="D007239" type="MeSH"></TargetEntity><TargetEntity id="-367065996" type="omicsDisease"></TargetEntity><TargetEntity id="799" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Hypogammaglobulinemia - China - Dec-1999</FirstLaunched><FirstLaunched>Infectious disease - China - Dec-1999</FirstLaunched><FirstLaunched>Thrombocytopenic purpura - China - Dec-1999</FirstLaunched></PhaseHighestDetailed><IndicationsPrimary><Indication id="1133">Thrombocytopenic purpura</Indication><Indication id="3839">Hypogammaglobulinemia</Indication><Indication id="746">Infectious disease</Indication></IndicationsPrimary><ActionsSecondary><Action id="393">Immunostimulant</Action><Action id="59620">Unspecified drug target</Action></ActionsSecondary><Technologies><Technology id="4">Immunoglobulin</Technology><Technology id="582">Antibody polyclonal</Technology><Technology id="648">Intravenous formulation</Technology><Technology id="761">Biological therapeutic</Technology><Technology id="1651">Blood constituents</Technology></Technologies><EphmraCodes><Ephmra><Code>L3</Code><Name>IMMUNOSTIMULATING AGENTS</Name></Ephmra></EphmraCodes><LastModificationDate>2013-09-24T16:26:29.000Z</LastModificationDate><ChangeDateLast>2013-09-24T00:00:00.000Z</ChangeDateLast><AddedDate>2012-11-22T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkType="Company" linkID="14959"&gt;Sino-Korean Anhui Green Cross Biological Products&lt;/ulink&gt; has developed and launched a plasma-derived pH4 human immunoglobulin for the intraveous treatment of primary and/or secondary hypogammaglobulinemia, thrombocytopenic purpura and severe Infections. The product was assumed to be launched in China shortly after its approval there in 1999 [&lt;ulink linkType="Reference" linkID="1342194"&gt;1342194&lt;/ulink&gt;], [&lt;ulink linkType="Reference" linkID="1342234"&gt;1342234&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="3839">Hypogammaglobulinemia</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342194" type="CORPORATE"></Source></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="746">Infectious disease</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342194" type="CORPORATE"></Source></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="1133">Thrombocytopenic purpura</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342194" type="CORPORATE"></Source></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="3839">Hypogammaglobulinemia</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342234" type="OTHER"></Source></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="1133">Thrombocytopenic purpura</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342234" type="OTHER"></Source></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="14959">Sino-Korean Anhui Green Cross Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="746">Infectious disease</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1999-12-31T00:00:00.000Z</StatusDate><Source id="1342234" type="OTHER"></Source></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></Drug></ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordsOutput>